Clinical trial
Study to Assess Safety and Quality of Life of Patients Using Biojector Versus…
NCT00333736 · Canadian Immunodeficiency Research Collaborative, Other · Completed
Key facts
| NCT number | NCT00333736 |
|---|---|
| Title | Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration |
| Official title | Prospective Study to Assess Patient Satisfaction, Quality of Life and Adverse Events of Patients Using the Biojector Versus Standard Needles for Enfuvirtide Administration |
| Lead sponsor | Canadian Immunodeficiency Research Collaborative, Other |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Human Immunodeficiency Virus |
| Intervention type | Device |
| Interventions | Biojector |
| Enrollment | 337 |
| Start date | May 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2008 |
| First posted | Jun 6, 2006 |
| Last update posted | Jun 5, 2012 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: